Prostatype Genomics AB (FRA:PGO0) Total Assets : €2.86 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Prostatype Genomics AB Total Assets?

Prostatype Genomics AB's Total Assets for the quarter that ended in Jun. 2024 was €2.86 Mil.

During the past 12 months, Prostatype Genomics AB's average Total Assets Growth Rate was 56.70% per year. During the past 3 years, the average Total Assets Growth Rate was 46.20% per year.

During the past 5 years, Prostatype Genomics AB's highest 3-Year average Total Assets Growth Rate was 46.20%. The lowest was 19.20%. And the median was 32.70%.

Total Assets is connected with ROA %. Prostatype Genomics AB's annualized ROA % for the quarter that ended in Jun. 2024 was 0.00%. Total Assets is also linked to Revenue through Asset Turnover. Prostatype Genomics AB's Asset Turnover for the quarter that ended in Jun. 2024 was 0.00.

Prostatype Genomics AB Total Assets Historical Data

The historical data trend for Prostatype Genomics AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Total Assets Chart

Prostatype Genomics AB Annual Data

Trend

Jun18

Jun19

Dec21

Dec22

Dec23

Total Assets

1.92

1.65

3.91

2.82

4.40

Prostatype Genomics AB Quarterly Data
	Jun18	Jun19	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Jun24
Total Assets	Get a 7-Day Free Trial												2.82	2.12	2.98	4.40	2.86

Prostatype Genomics AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Prostatype Genomics AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	2.206	+	2.195
	=	4.40

Prostatype Genomics AB's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	1.177	+	1.682
	=	2.86

Prostatype Genomics AB (FRA:PGO0) Total Assets Explanation

Total Assets is connected with ROA %.

Prostatype Genomics AB's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	0	/	( (4.4	+	2.859)	/ 2 )
	=	0	/	3.6295
	=	0.00 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Prostatype Genomics AB's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	0	/	( (4.4	+	2.859)	/ 2 )
=	0	/	3.6295
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Prostatype Genomics AB Total Assets Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (FRA:PGO0) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

PROGEN:Sweden

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB Headlines

No Headlines